title: A physical mechanism to explain the delivery of chemical penetration enhancers into skin during transdermal sonophoresis - Insight into the observed synergism.
abstract: The synergism between low-frequency sonophoresis (LFS) and chemical penetration enhancers (CPEs), especially surfactants, in transdermal enhancement has been investigated extensively since this phenomenon was first observed over a decade ago. In spite of the identifying that the origin of this synergism is the increased penetration and subsequent dispersion of CPEs in the skin in response to LFS treatment, to date, no mechanism has been directly proposed to explain how LFS induces the observed increased transport of CPEs. In this study, we propose a plausible physical mechanism by which the transport of all CPEs is expected to have significantly increased flux into the localized-transport regions (LTRs) of LFS-treated skin. Specifically, the collapse of acoustic cavitation microjets within LTRs induces a convective flux. In addition, because amphiphilic molecules preferentially adsorb onto the gas/water interface of cavitation bubbles, amphiphiles have an additional adsorptive flux. In this sense, the cavitation bubbles effectively act as carriers for amphiphilic molecules, delivering surfactants directly into the skin when they collapse at the skin surface as cavitation microjets. The flux equations derived for CPE delivery into the LTRs and non-LTRs during LFS treatment, compared to that for untreated skin, explain why the transport of all CPEs, and to an even greater extent amphiphilic CPEs, is increased during LFS treatment. The flux model is tested with a non-amphiphilic CPE (propylene glycol) and both nonionic and ionic amphiphilic CPEs (octyl glucoside and sodium lauryl sulfate, respectively), by measuring the flux of each CPE into untreated skin and the LTRs and non-LTRs of LFS-treated skin. The resulting data shows very good agreement with the proposed flux model.
authors.affiliation: Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
authors.forename: Baris E
authors.initials: BE
authors.lastname: Polat
authors.forename: William M
authors.initials: WM
authors.lastname: Deen
authors.forename: Robert
authors.initials: R
authors.lastname: Langer
authors.forename: Daniel
authors.initials: D
authors.lastname: Blankschtein
mesh_terms: D000162:Acoustics / Q000295:instrumentation; D000279:Administration, Cutaneous; D000818:Animals; D016503:Drug Delivery Systems; D005260:Female; D005960:Glucosides / Q000378:metabolism; D008954:Models, Biological; D019946:Propylene Glycol / Q000378:metabolism; D012867:Skin / Q000378:metabolism; D012869:Skin Absorption; D012967:Sodium Dodecyl Sulfate / Q000378:metabolism; D013501:Surface-Active Agents / Q000378:metabolism*; D013552:Swine
chemical_list: D005960:Glucosides; D013501:Surface-Active Agents; C018619:octyl-beta-D-glucoside; D012967:Sodium Dodecyl Sulfate; D019946:Propylene Glycol
references.citation: J Pharm Sci. 2011 Apr;100(4):1387-97
references.pmid: 20963845
references.citation: J Pharm Sci. 2004 Nov;93(11):2733-45
references.pmid: 15389675
references.citation: Anat Rec. 1997 Apr;247(4):455-61
references.pmid: 9096784
references.citation: J Cosmet Sci. 2007 May-Jun;58(3):229-44
references.pmid: 17598025
references.citation: Biomaterials. 2011 Jan;32(3):933-41
references.pmid: 20971504
references.citation: J Control Release. 2012 Feb 28;158(1):85-92
references.pmid: 22062691
references.citation: Chemphyschem. 2001 Sep 17;2(8-9):536-8
references.pmid: 23686992
references.citation: J Control Release. 2010 Jul 1;145(1):26-32
references.pmid: 20346994
references.citation: J Cosmet Sci. 2003 Jan-Feb;54(1):29-46
references.pmid: 12644857
references.citation: J Pharm Sci. 2007 Dec;96(12):3263-82
references.pmid: 17887176
references.citation: J Pharm Sci. 2002 Jan;91(1):91-100
references.pmid: 11782900
references.citation: J Invest Dermatol. 2006 May;126(5):1095-101
references.pmid: 16528354
references.citation: J Phys Chem B. 2005 Sep 29;109(38):17799-801
references.pmid: 16853282
references.citation: J Control Release. 2011 Jun 30;152(3):330-48
references.pmid: 21238514
references.citation: J Pharm Sci. 2000 Jul;89(7):892-900
references.pmid: 10861590
references.citation: J Pharm Sci. 2011 Feb;100(2):512-29
references.pmid: 20740667
references.citation: J Control Release. 2005 Oct 20;107(3):484-94
references.pmid: 16165244
references.citation: J Invest Dermatol. 2007 Dec;127(12):2832-46
references.pmid: 17554365
references.citation: Expert Opin Drug Deliv. 2010 Dec;7(12):1415-32
references.pmid: 21118031
references.citation: J Pharm Sci. 2008 Feb;97(2):906-18
references.pmid: 17887123
references.citation: J Am Chem Soc. 2007 Feb 28;129(8):2250-8
references.pmid: 17279753
references.citation: Ultrason Sonochem. 2002 Sep;9(4):209-13
references.pmid: 12219583
references.citation: Pediatr Emerg Care. 2006 May;22(5):339-45
references.pmid: 16714961
references.citation: J Cosmet Sci. 2007 Mar-Apr;58(2):109-33
references.pmid: 17520152
references.citation: J Phys Chem B. 2011 Feb 17;115(6):1394-402
references.pmid: 21222449